Research Grade Tafasitamab

Catalog #: DHD10803 Specific References (0) DATASHEET

SEC-HPLC for Research Grade Tafasitamab ?>

Flow Cytometry for Research Grade Tafasitamab ?>

Host species: Humanized

Isotype: IgG1-G2-kappa

Applications: Research Grade Biosimilar

Expression system: Mammalian Cells

Overview

Catalog No.

DHD10803

Expression system

Mammalian Cells

Species reactivity

Human

Host species

Humanized

Isotype

IgG1-G2-kappa

Clonality

Monoclonal

Applications

Research Grade Biosimilar

Target

CD19, Differentiation antigen CD19, T-cell surface antigen Leu-12, B-lymphocyte antigen CD19, B-lymphocyte surface antigen B4

Concentration

6.03 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P15391

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Alternative Names

CD19, MOR-00208, MOR-208, XENP-5574, XMP-5574, XmAb-5574, Xmab-CD19, CAS: 1422527-84-1

Clone ID

Tafasitamab

Note

For research use only. Not suitable for clinical or therapeutic use.

Data Image

SDS-PAGE

SDS PAGE for Tafasitamab
SEC-HPLC

The purity of this product is >95% as determined by SEC-HPLC.
Flow Cytometry

Figure 3. Binding specificity and cell-cell linkage induced by biHSNPs. Target cells were incubated with FITC-labeled, antibody-coated HSNPs at 4 ℃ for 30 min, followed by flow cytometry analysis to confirm binding specificity D) Verification of biHSNPs binding to CD3+ cells using PBMCs as the CD3+ cell line. E) Verification of biHSNPs binding to CD19+/CD20+ cells using Raji cells as the target. F)Verification of biHSNPs binding to CD16+ cells using PBMCs as the CD16+ cell line. G) Verification of biHSNPs binding to CD19+/CD20+ cells usingRaji cells as the target. Figure S6. FACS binding results of HSNPαCD3, HSNPαCD19, HSNPαCD20, HSNPαCD3+αCD19 and HSNPαCD3+αCD20 with Jurkat cells as CD3+ cell lines.
Data sourced from citation (PMID: 40789685)

References

Datasheet

Document Download

Research Grade Tafasitamab.pdf

$ 800

Product specifications

1 mg 800 5 mg 2240 25 mg 5820

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here